ABCC2 p.Pro1158Ala
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 17494643
[PubMed]
Letourneau IJ et al: "Mutational analysis of a highly conserved proline residue in MRP1, MRP2, and MRP3 reveals a partially conserved function."
No.
Sentence
Comment
5
As observed for MRP1-Pro1150Ala, LTC4 transport by MRP2-Pro1158Ala was decreased.
X
ABCC2 p.Pro1158Ala 17494643:5:56
status: NEW122 As shown in Fig. 2, all three Pro to Ala mutants (MRP1-Pro1150Ala, MRP2-Pro1158Ala, and MRP3-Pro1147Ala) were expressed at levels comparable to those of their corresponding wild-type proteins, confirming that the Pro residue at this position is not required for expression of the MRP proteins in the plasma membrane of mammalian cells.
X
ABCC2 p.Pro1158Ala 17494643:122:72
status: NEW141 Protein expression levels of mutants MRP1-Pro1150Ala, MRP2-Pro1158Ala, and MRP3-Pro1147Ala and their corresponding wild-type proteins.
X
ABCC2 p.Pro1158Ala 17494643:141:59
status: NEW148 Vesicular transport of 3 H-labeled organic anions by mutants MRP1-Pro1150Ala, MRP2-Pro1158Ala, and MRP3-Pro1147Ala.
X
ABCC2 p.Pro1158Ala 17494643:148:83
status: NEW165 Mutations MRP1-Pro1150Ala, MRP2-Pro1158Ala, and MRP3-Pro1147Ala Do Not Affect [␥-32 P]8N3ATP Binding but Decrease Vanadate-Induced Trapping of [␣-32 P]8N3ADP.
X
ABCC2 p.Pro1158Ala 17494643:165:32
status: NEW175 Thus, 8N3ADP trapping by the MRP3 mutant was decreased as observed with the MRP1-Pro1150Ala and MRP2-Pro1158Ala mutants, although under different conditions.
X
ABCC2 p.Pro1158Ala 17494643:175:101
status: NEW208 Thus, although 8N3ATP binding to MRP1-Pro1150Ala, MRP2-Pro1158Ala, and MRP3-Pro1147Ala remained unchanged, the level of vanadate-induced 8N3ADP trapping was very low for all three mutant transporters.
X
ABCC2 p.Pro1158Ala 17494643:208:55
status: NEW59 The template for generating the MRP2-Pro1158Ala mutant was created by subcloning a 2.2-kb ApaI/ClaI fragment into pGEM-7Zf(ϩ) (Promega, Madison, WI).
X
ABCC2 p.Pro1158Ala 17494643:59:37
status: NEW62 Mutagenesis was performed according to the manufacturer`s instructions with the following sense primers (substituted nucleotides are underlined, and in both cases, the substitution created a BstUI restriction site, which was used to confirm the successful introduction of the nucleotide substitutions): MRP2-Pro1158Ala, 5Ј-C ACC AGG TCC GCG ATC TAC TCT C-3Ј (BstUI) and MRP3-Pro1147Ala, 5Ј-GTC AGC CGC TCC GCG ATC TAC TCC C-3Ј (BstUI).
X
ABCC2 p.Pro1158Ala 17494643:62:308
status: NEW63 The MRP2-Pro1158Ala mutation was subcloned back into pcDNA3.1(-) MRP2 as a 1.75-kb Bsu36I/SfiI fragment and the MRP3-Pro1147Ala mutation was subcloned into pcDNA3.1(ϩ) MRP3 as a 1.24-kb AgeI/SacII fragment (Oleschuk et al., 2003).
X
ABCC2 p.Pro1158Ala 17494643:63:9
status: NEW120 To determine whether this expression was also true for the corresponding MRP2-Pro1158Ala and MRP3-Pro1147Ala mutants, these mutations were created in pcDNA3.1(Ϯ)-based MRP2 and MRP3 expression vectors and then transfected into HEK293T cells.
X
ABCC2 p.Pro1158Ala 17494643:120:78
status: NEW130 For MRP2-Pro1158Ala, LTC4 transport was also decreased by ϳ50% whereas it was significantly increased (1.8-fold) for MRP3-Pro1147Ala (Fig. 3A).
X
ABCC2 p.Pro1158Ala 17494643:130:9
status: NEW137 In contrast to LTC4 uptake, E217betaG transport by MRP2 and MRP3 was unaffected by the Pro1158Ala and Pro1147Ala mutations, respectively (Fig. 3B).
X
ABCC2 p.Pro1158Ala 17494643:137:87
status: NEW140 In contrast, MTX transport by the MRP2-Pro1158Ala mutant remained the same as that of wild-type MRP2 (Fig. 3C), whereas FIG. 2.
X
ABCC2 p.Pro1158Ala 17494643:140:39
status: NEW160 To determine whether the reduced LTC4 transport by MRP2-Pro1158Ala was associated with reduced substrate binding, [3 H]LTC4 photolabeling of this mutant was compared with that of wild-type MRP2.
X
ABCC2 p.Pro1158Ala 17494643:160:56
status: NEW163 Similarly, MRP2-Pro1158Ala was photolabeled by [3 H]LTC4 to the same extent as wild-type MRP2 despite the reduced LTC4 transport activity of the mutant (Fig. 4B).
X
ABCC2 p.Pro1158Ala 17494643:163:16
status: NEW167 When MRP2-Pro1158Ala and MRP3-Pro1147Ala were photolabeled with [␥-32 P]8N3ATP, the intensity of the signals observed with the mutant and wild-type proteins was also comparable (Fig. 5), suggesting that ATP can bind to the Pro mutants as well as it does to their wild-type counterparts.
X
ABCC2 p.Pro1158Ala 17494643:167:10
status: NEW170 When the MRP2-Pro1158Ala and MRP3-Pro1147Ala mutants were examined under the same conditions, a significant decrease (50%) in the level of vanadate-induced 8N3ADP trapping by MRP2-Pro1158Ala was also observed (Fig. 6B), whereas no trapping of nucleotide was detected with either wild-type MRP3 or its Pro1147Ala mutant (data not shown).
X
ABCC2 p.Pro1158Ala 17494643:170:14
status: NEWX
ABCC2 p.Pro1158Ala 17494643:170:180
status: NEW
PMID: 20082599
[PubMed]
Jemnitz K et al: "ABCC2/Abcc2: a multispecific transporter with dominant excretory functions."
No.
Sentence
Comment
97
Mutant Predicted location Substrate Activity changes Reference Human MRP2 Δ1-188 TMD0 LTC4 ↓ Fernandez et al., 2002 K316A JC, TM6 GMF ↔ Ryu et al., 2000 K324A TM6 GMF ↓ Ryu et al., 2000 K329A TM6 GMF ↔ Ryu et al., 2000 R412G DJ IC MTX ↓ Hulot et al., 2005 W417I IC, TM7-TM8 E2-17βG ↓ Hirouchi et al., 2004 LTC4 ↓ DNP-SG ↓ H439A TM8 GMF ↔ Ryu et al., 2000 K483A IC, JM, TM9 GMF ↓ Ryu et al., 2000 K590A JC, TM11 GMF ↔ Ryu et al., 2000 S789F NBD1 E2-17βG ↓ Hirouchi et al., 2004 LTC4 ↓ DNP-SG ↓↓ R1023A EC, JM, TM13 GMF ↔ Ryu et al., 2000 H1042A TM13 GMF ↔ Ryu et al., 2000 R1100A JC, TM14 GMF ↔ Ryu et al., 2000 P1158A IC, JM, TM15 LTC4 ↓↓ Letourneau et al., 2007 E2-17βG ↔ MTX ↔ Table 1. continued on next page Mutant Predicted location Substrate Activity changes Reference I1173F DJ IC, TM15-16 LTC4 No act Keitel et al., 2003 E2-17βG No act R1210A EC, JC, TM16 GMF ↓↓ Ryu et al., 2000 R1230A TM16 GMF ↔ R1257A JC, TM17 GMF ↓↓ W1254A JC, TM17 E2-17βG ↓↓ Ito et al., 2001a W1254C ↓↓ W1254F ↔ W1254Y ↔ W1254A JC, TM17 LTC4 ↓↓ Ito et al., 2001b W1254C ↓↓↓ W1254F ↓↓ W1254Y ↓↓ W1254A JC, TM17 MTX ↓↓ Ito et al., 2001a W1254C ↓↓ W1254F ↓↓ W1254Y ↓↓↓ A1450T NBD2 E2-17βG ↓↓ Hirouchi et al., 2004 LTC4 ↓↓ DNP-SG ↓↓ Rat Mrp2 K308M IC, JM, TM6 TLC-S ↔ Ito et al., 2001b DNP-G ↑ LTC4 ↓ E3040G ↔ K320M TM6 TLC-S ↑ DNP-G ↑ LTC4 ↓ E3040G ↑ K325M TM6 TLC-S ↓* DNP-G ↓↓↓* LTC4 ↓↓↓* E3040G ↓ D329N TM6 TLC-S ↔ DNP-G ↓ LTC4 ↓↓↓* E3040G ↓ R586L TM11 TLC-S ↓ DNP-G ↓↓* LTC4 ↓↓* E3040G ↔ R1019M IC, JM, TM13 TLC-S ↔ DNP-G ↑* LTC4 ↔ E3040G ↔ R1096L TM14 TLC-S ↑ DNP-G ↑ LTC4 ↔ E3040G ↔ EC, extracellular; IC, intracellular; JC, near the cytosol in the membrane; JM, juxtamembrane; TLC-S, tauro-litocholate-sulfate; GMF, glutathione- methyl-fluorescein; ↑, activity over control>1.2; ↔, 1.2>activity over control>0.8; ↓, 0.8>activity over control>0.5; ↓↓, 0.5>activity over control>0.1; ↓↓↓, 0.1>activity over control.
X
ABCC2 p.Pro1158Ala 20082599:97:755
status: NEW